^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Multiple Myeloma |
| Drug: | Xpovio (selinexor) (XPO1 inhibitor) + carfilzomib (Proteasome inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
12/14/2021
Excerpt:
Multiple Myeloma:..Therapy for Previously Treated Multiple Myeloma...The following regimen was added: Selinexor/carfilzomib/dexamethasone
Secondary therapy:
dexamethasone
